Published in Laryngoscope on March 01, 2010
Modern concepts in facial nerve reconstruction. Head Face Med (2010) 1.11
Outcomes following temporal bone resection. Laryngoscope (2010) 0.93
Fluorescently labeled peptide increases identification of degenerated facial nerve branches during surgery and improves functional outcome. PLoS One (2015) 0.79
Facial nerve reconstruction following radical parotidectomy and subtotal petrosectomy for advanced malignant parotid neoplasms. Ann Maxillofac Surg (2016) 0.75
Lower lip suspension with gore-tex suture: technique and literature review. Eplasty (2014) 0.75
Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma. Mol Imaging Biol (2013) 1.67
Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg (2011) 1.62
Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life. Laryngoscope (2006) 1.59
Stereomicroscopic fluorescence imaging of head and neck cancer xenografts targeting CD147. Cancer Biol Ther (2008) 1.57
Robotic-assisted surgery for primary or recurrent oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg (2010) 1.52
Fully automated analysis using BRAINS: AutoWorkup. Neuroimage (2010) 1.52
Dynasplint for the management of trismus after treatment of upper aerodigestive tract cancer: a retrospective study. Ear Nose Throat J (2011) 1.45
Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head Neck (2008) 1.42
Utility of CT surveillance for primary site recurrence of squamous cell carcinoma of the head and neck. Head Neck (2010) 1.39
Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Arch Otolaryngol Head Neck Surg (2007) 1.33
Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol (2012) 1.30
Functional outcomes after transoral robotic surgery for head and neck cancer. Otolaryngol Head Neck Surg (2009) 1.29
The role of free tissue transfer in the reconstruction of massive neglected skin cancers of the head and neck. Arch Facial Plast Surg (2003) 1.17
Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer (2006) 1.16
Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis. Mol Immunol (2008) 1.16
Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment. Cancer Biol Ther (2007) 1.16
Free tissue transfer to manage salvage laryngectomy defects after organ preservation failure. Laryngoscope (2007) 1.16
Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin Cancer Res (2009) 1.16
Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy. PLoS One (2010) 1.13
Transoral robotic-assisted surgery for head and neck squamous cell carcinoma: one- and 2-year survival analysis. Arch Otolaryngol Head Neck Surg (2010) 1.10
Assessment and incidence of salivary leak following laryngectomy. Laryngoscope (2012) 1.10
Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma. Laryngoscope (2011) 1.09
IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques. Mol Imaging Biol (2015) 1.08
Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope (2013) 1.04
Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines. Otolaryngol Head Neck Surg (2007) 1.00
Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice. Clin Exp Metastasis (2004) 0.98
Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice. Otolaryngol Head Neck Surg (2013) 0.97
Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer. Laryngoscope (2010) 0.97
(18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. Mol Imaging Biol (2012) 0.96
Incidence and outcomes of stricture formation postlaryngectomy. Otolaryngol Head Neck Surg (2011) 0.95
Expandable tracheal stenting for benign disease: worth the complications? Ann Otol Rhinol Laryngol (2006) 0.94
Closure of post-laryngectomy pharyngocutaneous fistulae. Head Neck Oncol (2011) 0.94
EGFR expression in advanced head and neck cutaneous squamous cell carcinoma. Head Neck (2011) 0.93
Outcomes following temporal bone resection. Laryngoscope (2010) 0.93
Optical imaging predicts tumor response to anti-EGFR therapy. Cancer Biol Ther (2010) 0.93
Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma. Cancer Biol Ther (2013) 0.92
Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer. Arch Otolaryngol Head Neck Surg (2008) 0.92
Free flap reconstruction of lateral mandibular defects: indications and outcomes. Otolaryngol Head Neck Surg (2011) 0.91
Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis. J Oral Pathol Med (2014) 0.91
Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model. Anticancer Drugs (2010) 0.91
Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells. Mol Cancer Res (2011) 0.91
Robot-assisted surgery for upper aerodigestive tract neoplasms. Arch Otolaryngol Head Neck Surg (2009) 0.90
Transoral robotic surgery for oropharyngeal and tongue cancer in the United States. Laryngoscope (2014) 0.90
CD147 and AGR2 expression promote cellular proliferation and metastasis of head and neck squamous cell carcinoma. Exp Cell Res (2012) 0.90
Zygomatic-maxillary buttress reconstruction of midface defects with the osteocutaneous radial forearm free flap. Head Neck (2008) 0.90
Primary versus delayed tracheoesophageal puncture for laryngopharyngectomy with free flap reconstruction. Laryngoscope (2011) 0.90
Outcomes in head and neck reconstruction by surgical site and donor site. Laryngoscope (2013) 0.90
Influence of social support on health-related quality of life outcomes in head and neck cancer. Head Neck (2007) 0.90
Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy. Anticancer Drugs (2011) 0.89
Functional outcomes of fibula and osteocutaneous forearm free flap reconstruction for segmental mandibular defects. Laryngoscope (2010) 0.89
Management of the N0 neck in recurrent laryngeal squamous cell carcinoma. Laryngoscope (2010) 0.88
Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2012) 0.88
Current strategies in reconstruction of maxillectomy defects. Arch Otolaryngol Head Neck Surg (2011) 0.88
Closure of laryngectomy defects in the age of chemoradiation therapy. Head Neck (2011) 0.87
Assessment of tissue autofluorescence and reflectance for oral cavity cancer screening. Otolaryngol Head Neck Surg (2011) 0.87
Validation of ultrasonography to evaluate murine orthotopic oral cavity tumors. ORL J Otorhinolaryngol Relat Spec (2006) 0.87
Free flap reconstruction of self-inflicted submental gunshot wounds. Craniomaxillofac Trauma Reconstr (2011) 0.85
Fistula analysis after radial forearm free flap reconstruction of hypopharyngeal defects. Laryngoscope (2008) 0.85
Antibody-based imaging strategies for cancer. Cancer Metastasis Rev (2014) 0.84
Outcomes of intubation in difficult airways due to head and neck pathology. Ear Nose Throat J (2012) 0.83
Functional outcomes of fibula and osteocutaneous forearm free flap reconstruction for segmental mandibular defects. Laryngoscope (2010) 0.83
Intraoperative round window electrocochleography and speech perception outcomes in pediatric cochlear implant recipients. Ear Hear (2015) 0.83
Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck. Int J Oncol (2007) 0.82
Harmonic Scalpel versus electrocautery and surgical clips in head and neck free-flap harvesting. Ear Nose Throat J (2014) 0.82
The ulnar fasciocutaneous free flap in head and neck reconstruction. Laryngoscope (2002) 0.82
A comparison of negative-pressure dressings versus Bolster and splinting of the radial forearm donor site. Otolaryngol Head Neck Surg (2005) 0.82
A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma. Oral Oncol (2013) 0.82
EMMPRIN expression is required for response to bevacizumab therapy in HNSCC xenografts. Cancer Lett (2008) 0.82
Fluorescent detection of rat parathyroid glands via 5-aminolevulinic acid. Laryngoscope (2008) 0.81
Bone morphogenetic protein 6 expression in oral cavity squamous cell cancer is associated with bone invasion. Laryngoscope (2013) 0.81
Increased likelihood of long-term gastrostomy tube dependence in head and neck cancer survivors without partners. Head Neck (2012) 0.81
Barriers to early detection and treatment of head and neck squamous cell carcinoma in African American men. Head Neck (2009) 0.80
Use of recombinant bone morphogenetic protein 2 in free flap reconstruction for osteonecrosis of the mandible. J Oral Maxillofac Surg (2011) 0.80
Concern Reconstruction of scalp defects with the radial forearm free flap. Head Neck Oncol (2012) 0.80
Evaluation of tyrosine receptor kinases in the interactions of head and neck squamous cell carcinoma cells and fibroblasts. Oral Oncol (2012) 0.80
Functional outcomes following secondary free flap reconstruction of the head and neck. Laryngoscope (2009) 0.80
Assessment of donor site morbidity for free radial forearm osteocutaneous flaps. Microsurgery (2012) 0.80
Breast cancer imaging using the near-infrared fluorescent agent, CLR1502. Mol Imaging (2014) 0.79
In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts. ORL J Otorhinolaryngol Relat Spec (2008) 0.79
Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor. Laryngoscope (2012) 0.79
CD147 expression in advanced cutaneous squamous cell carcinoma. J Cutan Pathol (2012) 0.79
Outcomes of recurrent head and neck cutaneous squamous cell carcinoma. J Skin Cancer (2011) 0.78
Postoperative reirradiation for mucosal head and neck squamous cell carcinomas. Arch Otolaryngol Head Neck Surg (2009) 0.78
Hardware removal after osseous free flap reconstruction. Otolaryngol Head Neck Surg (2013) 0.78
Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2012) 0.78
Free tissue transfer for head and neck reconstruction in solid organ transplant patients. Head Neck (2011) 0.78